Stephen F. Flatt - Mar 8, 2023 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role: CEO, Director
Signature: /s/ Stephen F. Flatt
Stock symbol: NHC
Transactions as of: Mar 8, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/9/2023, 05:15 PM
Previous filing: Jan 4, 2023
Next filing: Nov 22, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NHC	Common Stock	Award	$0	+1.5K	+2.71%	$0.00	57K	Mar 8, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NHC	Option to Purchase Common Stock	Award	$0	+15K		$0.00	15K	Mar 8, 2023	Common Stock	15K	$53.94	Direct	F2, F3
holding	NHC	Option to Purchase Common Stock						14.2K	Mar 8, 2023	Common Stock	14.2K	$63.96	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026.
F2	These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3	This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026.